Skip to content

Pregabalin in pain control after abdominal hysterectomy

Study of the effects of pregabalin in postoperative pain control in general total intravenous anesthesia, general inhalation anesthesia and combined anesthesia after abdominal hysterectomy. - Pregpost

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2010-024538-51-ES
Enrollment
180
Registered
2012-01-19
Start date
2012-03-02
Completion date
Unknown
Last updated
2025-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The presence of acute postoperative pain remains a major cause of preoperative morbidity.The objective is to evaluate the analgesic efficacy of pregabalin in the postoperatory of abdominal hysterectomy associated with 3 types of anesthesia.

Interventions

Trade Name: Lyrica Pharmaceutical Form: Capsule, hard INN or Proposed INN: pregabalina CAS Number: 148553-50-8 Current Sponsor code: ssgt05 Other descriptive name: PREGABALIN Concentration unit: mg mi

Sponsors

Silvia Gil Trujillo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients scheduled for abdominal hysterectomy. -Age 18-70 years. - ASA I-II (anesthetic classification system to estimate the risk posed by anesthesia for the different states of the patient, I: no associated pathology and II: mild systemic disease, uncontrolled and disabling)-no known allergies to drugs to manage in the study. - Laboratory tests in the range of normal, and negative pregnant test. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 100 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 80

Exclusion criteria

Exclusion criteria: Impaired renal function. - History of alcohol or drugs. - Treatment with antacids and antidepressants. - History of diabetes or epilepsy. - Chronic treatment with steroids or at least 4 weeks before surgery. - Mental illness or inability to understand the Spanish. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Main Objective: Assess the analgesic efficacy of pregabalin in postoperative abdominal hysterectomy to associate with three types of anesthesia: general anesthesia total intravenous general anesthesia inhalation, and combined anesthesia (regional plus general);Secondary Objective: To assess preoperative anxiety. - Sleep. -Adverse effects (dizziness, somnolence,paresthesia, fatigue, headache, constipation, nausea and vomiting). - Satisfaction of the patient.;Primary end point(s): The analgesic efficacy of pregabalin was assessed by 2 variables in the immediate postoperative period and every 8hours within the first 48 hours, or verbal analog I scale (0-10) at rest and in motion. It is considered good pain control values less than or equal to 3. ;Timepoint(s) of evaluation of this end point: The variables will be recorded during the first 48 hours in the postoperative period. In the operating room, in reanimation care, and in the gynecological ward.

Secondary

MeasureTime frame
Secondary end point(s): Need to use rescue medication, pain scale according to WHO and milligrams of opiates consumed. anxiety. side effects. patient satisfaction. rest;Timepoint(s) of evaluation of this end point: 48 hours

Countries

Spain

Contacts

Public ContactArea de Ensayos Clínicos

Hospital General de Ciudad Real

eseguram@sescam.jccm.es0034926278000

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026